Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

复方胆通片 - NMPA Drug Approval Details

Approvals/NMPA/Unknown Drug

Approved

中药

Unknown Drug

广州市香雪制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Feb 12, 2020
Approval ID: 7LeaeXwghv2
Company: 广州市香雪制药股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeXwghv2
Approval Number: 国药准字Z44020348
Generic Name: 复方胆通片
Drug Type: 中药
Dosage Form: 片剂(糖衣)
Reg Date: 2020-02-12
Company Name: 广州市香雪制药股份有限公司
Production Company Name: 广州市香雪制药股份有限公司(药品上市许可持有人)
Production Company Address: 广州经济技术开发区科学城金峰园路2号
Company Detail Path: /organization/xiangxue-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 12, 2020

Approval ID

7LeaeXwghv2

Type

中药

Back to NMPA Approvals